跳至主要内容
临床试验/NCT01755481
NCT01755481已完成不适用

Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate

Arla Foods1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2012年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
800
试验地点
1
主要终点
Infections episodes (gastrointestinal and upper and lower respiratory infections)

研究概览

简要总结

To evaluate the effects of feeding an infant formula containing L. paracasei ssp. paracasei strain F19 or Whey Protein Concentrate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 2 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • (formula-fed group):
  • healthy infants of mothers who could not or voluntarily resigned completely from breast-feeding at infant age 14 plus/minus 3 days
  • Inclusion criteria (breast-fed group):
  • healthy infants exclusively breast-fed from birth and mothers intending to breastfeed >80% until at least 5th month of age (meaning through the 4th month of age).
  • Inclusion criteria (all infants):
  • delivered between 37 and 42 weeks of gestation birth weight >2500 g and <4000 g parent or the subject's legal representative speak and understand Chinese

排除标准

  • (formula-fed group):
  • fully or partially breast-fed infants infants breast-fed >20%
  • Exclusion criteria (breast-fed group):
  • infants fed >20% infant formula
  • Exclusion criteria (all infants):
  • malformations, handicaps or congenital diseases that could affect normal feeding or growth treatment with antibiotics

研究组 & 干预措施

Probiotics F19

Experimental

F19 in an infant formula

干预措施: Probiotic (Other)

Whey protein concentrate

Experimental

Whey protein concentrate in an infant formula

干预措施: Whey protein concentrate (Other)

结局指标

主要结局

Infections episodes (gastrointestinal and upper and lower respiratory infections)

时间窗: 4 yrs

次要结局

未报告次要终点

研究者

发起方
Arla Foods
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Feeding Infant Formula With Added Probiotics and... | 临床试验